Better technology for better medicines
Our moleculer superintelligence platform delivers highly differentiated drug candidates, optimized for patient and partner impact
Optimized medicines for optimized profiles
Our AI technologies, Enchant and NeuralPLexer, drive a high-throughput experimental platform that converts novel molecular designs into biological insights each week
Exploring multiple profiles in parallel ensures that we design molecules to solve the right problems in disease biology
Our moleculer superintelligence platform deeply explores chemical space, revealing novel mechanisms of action and delivering diverse high-quality leads
Innovation
Multimodal transformer and co-folding AI technologies built for the purpose of drug discovery
Automation
AI-driven, high-throughput experimentation to go from new molecular designs to new biological data each week
Execution
A proprietary pipeline of differentiated clinical candidates delivered at a pace years faster than the industry standard
Platform-driven pipeline of highly differentiated drug programs
We are unlocking the untapped potential of known targets and transforming seemingly undruggable targets into opportunities for breakthrough treatments
Highly selective, brain-penetrant inhibitor for HER2-driven cancers that has shown anti-tumor activity and tolerability in Phase 1/1b studies
Highly differentiated, brain-penetrant inhibitor for ovarian cancer, triple-negative breast cancer, and other solid tumor cancers
Highly selective CDK2/4 small-molecule inhibitor for HR+/HER2- metastatic breast cancer
Innovation through the collaboration of AI experts and drug hunters
By placing AI innovations in the hands of our seasoned drug hunters, we’re optimizing our path towards differentiated therapeutics
.jpg)
